Vertex Pharmaceuticals (VRTX) Total Debt (2009 - 2016)
Vertex Pharmaceuticals (VRTX) posted quarterly Total Debt of $75.0 million for Q4 2016, down 66.5% year-over-year from $223.9 million in Q1 2016, and down 74.81% quarter-over-quarter from $297.8 million in Q3 2016.
Vertex Pharmaceuticals (VRTX) Total Debt (2009 - 2016) Analysis & Trends
Vertex Pharmaceuticals' Total Debt history runs 6 years deep, the most recent figure standing at $75.0 million for Q4 2016.
- In Q4 2016, Total Debt fell 66.5% year-over-year to $75.0 million; the TTM figure through Dec 2016 stood at $75.0 million (down 66.5% YoY), while the FY2016 annual figure was $75.0 million, down 66.5% from the prior year.
- Total Debt for Q4 2016 stood at $75.0 million, down from $297.8 million in the prior quarter.
- The five-year high for Total Debt was $297.8 million in Q3 2016, with the low at $75.0 million in Q4 2016.
- The 3-year median for Total Debt is $294.8 million (2015), against an average of $266.3 million.
- Peak annual rise in Total Debt reached 0.99% in 2016, while the deepest fall reached 66.5% in 2016.
- Vertex Pharmaceuticals' Total Debt stood at $294.8 million in 2014, then dropped by 24.06% to $223.9 million in 2015, then plunged by 66.5% to $75.0 million in 2016.
- Business Quant data shows VRTX's Total Debt at $75.0 million in Q4 2016, $297.8 million in Q3 2016, and $296.5 million in Q2 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.07 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 9.34 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 546.77 Mn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 75.00 Mn |
| Sep 30, 2016 | 297.75 Mn |
| Jun 30, 2016 | 296.50 Mn |
| Mar 31, 2016 | 295.82 Mn |
| Dec 31, 2015 | 223.86 Mn |
| Sep 30, 2015 | 294.83 Mn |
| Jun 30, 2015 | 294.81 Mn |
| Mar 31, 2015 | 294.79 Mn |
| Dec 31, 2014 | 294.78 Mn |
| Sep 30, 2014 | 294.74 Mn |
| Sep 30, 2011 | 203.42 Mn |
| Mar 31, 2011 | 197.10 Mn |
| Dec 31, 2010 | 136.99 Mn |
| Sep 30, 2010 | 45.28 Mn |
| Jun 30, 2010 | 163.66 Mn |
| Dec 31, 2009 | 143.38 Mn |